AdenreleOlajideMD

Assistant Professor, Medicine, Vanderbilt University School of Medicine

Dr. Olajide is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Adenrele Olajide, MD, is a rheumatologist based in Nashville, TN, currently serving as an Attending Physician at Vanderbilt University Medical Center, Cabell Huntington Hospital, St. Mary's Medical Center, and University Physicians and Surgeons since 2009. He completed his rheumatology fellowship at NYU Grossman Long Island School of Medicine and his internal medicine residency at Nassau University Medical Center. Dr. Olajide is experienced in treating rheumatoid arthritis and has a publication in Cureus on pseudogout associated with zoledronic acid. He has received recognition as a Fellow from both the American College of Physicians and the American College of Rheumatology and holds a CMS Meaningful Use Stage 1 Certification.

NYU Grossman Long Island School of MedicineFellowship, Rheumatology, 2003 - 2005
Nassau University Medical CenterResidency, Internal Medicine, 2000 - 2003
University of IbadanClass of 1991

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Fellow American College of Physicians, 2012
Fellow American College of Rheumatology

PubMed

2 citations
A Case of Pseudogout Following Zoledronic Acid Administration.
Alexander C Hill, Rania Al Asmar, Adenrele A Olajide, Nesreen BenHamed
Cureus. 2021-06-13